Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

MalarVx

MalarVx
2012 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$1.05M LATEST DEAL AMOUNT
1 INVESTORS
Description

Operator of a bio-pharmaceutical company. The company is focused on the development of in vitro culture systems for the malaria parasite which will lead to the development of an effective whole-parasite vaccine.

Website
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Healthcare Services
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 307 Westlake Avenue North
  • Suite 200
  • Seattle, WA 98109
  • United States

+1 (206) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore MalarVx’s full profile, request a free trial.

MalarVx Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 21-Jun-2017 $1.05M 00.00 Completed Startup
1. Angel (individual) 23-Nov-2015 00000 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

MalarVx Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Keiretsu Forum Venture Capital Minority 000 0000 000000 0

MalarVx Executive Team (2)

Name Title Board
Seat
Contact
Info
James Davie Co-Founder, President & Chief Executive Officer
Paul Harris Ph.D Co-Founder & Vice President, Product Development